SEC EDGAR Filing Information

Form 10-Q -- Quarterly report [Sections 13 or 15(d)]

Period of Report: 2009-03-31
Filing Date Changed: 2009-05-08
Documents: 5

SEC Accession No.
0000936392-09-000246
Filing date: 2009-05-08
Accepted: 2009-05-08 15:56:40

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10-Q	a52400e10vq.htm	414099	FORM 10-Q
2	EX-10.1	a52400exv10w1.htm	132758	EX-10.1
3	EX-31.1	a52400exv31w1.htm	6780	EX-31.1
4	EX-31.2	a52400exv31w2.htm	6794	EX-31.2
5	EX-32.1	a52400exv32w1.htm	3569	EX-32.1

		0000936392-09-000246.txt	565628	Complete submission text file

Filer Information:

AVANIR PHARMACEUTICALS, INC. (Filer) (0000858803)
IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 09810620
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656
949-389-6700

Mailing Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656